New data suggest seltorexant may ease insomnia in MDD while limiting weight gain and potentially improving metabolic risk factors.
Jane Tiller, MD
Advertisement
Articles by Jane Tiller, MD
Phase 3 data show adjunctive seltorexant eases depression and insomnia with lessened weight gain and somnolence.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Psychiatric Times
1
Vol 43, Issue 7 - Interactive
2
AI Chatbots and the Erosion of Therapeutic Discomfort
3
Vagus Nerve Stimulation in Difficult-to-Treat Depression: When Does It Work Best?
4
Beyond Deprescribing: A Formula for Excellent Clinical Care
5